{"nct_id":"NCT03499353","title":"Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer","status":"TERMINATED","status_verified_date":"2021-10","start_date":"2018-08-27","start_date_type":"ACTUAL","primary_completion_date":"2020-09-23","primary_completion_date_type":"ACTUAL","completion_date":"2020-09-23","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["PFE"]}